American Pacific Borate lowers opex & increases revenues
American Pacific Borate and Lithium (ASX:ABR) today updated the market on its progress commercialising the Fort Cady Borate and Lithium Project in Southern California, USA.
Onsite testworks are progressing nicely, with boric acid being recovered from the commercial-scale cavern.
Encouragingly, operating costs per tonne of boric acid is expected to be reduced with an optimised design philosophy and better than expected heat retention within caverns.
This reduction will be achieved through the addition of cogeneration to decrease energy costs, solvent extraction and the flow through reduction of a set of crystallisers. The resulting process plant will also allow for a wider range of boric acid head grades.
ABR’s onsite testworks and bulk sampling program is ongoing and designed to: test the scoping study flowsheet; obtain bulk samples for equipment sizing; progress detailed engineering in preparation for the start of construction, and obtain product samples to provide to potential customers and partners.
Onsite infrastructure for current commercial scale cavern testworks at Fort Cady:
In parallel with ongoing testworks, ABR is also exploring options to sell by-product gypsum into the expansive Californian agricultural market. The US gypsum soil amendment market initially estimated at US$30 to US$40 million per year by the company’s US-based fertiliser consultants, Context Inc.
However, the size of the market share ABR can secure remains to be seen at this stage, so if considering this stock for your portfolio do your own research and seek professional financial advice.
As an agricultural product, gypsum is generally applied to soils in areas where sodium levels are high to neutralise the effect of sodium on crops. It is also applied in areas where calcium levels are low, or to crops that require calcium for their growth like tomatoes and peanuts. Gypsum is also widely used in the construction of walls and ceilings in the construction industry. Boron-based gypsum improves product performance, user convenience and process efficiency.
Recent positive discussions with local gypsum suppliers have been encouraging, suggesting that ABR should be able to sell gypsum into local markets and that its enriched boron gypsum will be highly sought after. The sale of by-product gypsum is also likely to result in minimal waste products from the operations.
Interestingly, Context Inc.’s recently commissioned study into US micronutrient markets for boron and SOP also found that boron is the second most used micronutrient by value and that its annual micronutrient value is expected to grow by a strong 9 per cent CAGR through to 2022.
This study reinforces ABR’s North American specialty fertiliser market target and echoes the view that its boron fertiliser and boron-enriched gypsum will very much coveted in both local Californian and wider US domestic markets.
On top of this, ABR’s definitive feasibility study (DFS) is on track for completion in the second half of the calendar year.
ABR will also be lodging its air quality permit application in the coming weeks to enable commencement of construction, subject to financing.
ABR CEO, Michael Schlumpberger, said: “We are very pleased with the progress of the onsite testworks. We are also pleased with the initial results of the value engineering program as part of our DFS showing we can reduce opex by around 10% whilst providing for a wider range of head grades.
“In addition we now believe that we can sell by-product gypsum into the Californian market which will increase by-product credit revenue and reduce capex and opex associated with tailings facilities. We are now in an exciting position to be targeting an operation that produces minimal waste products,” added Schlumpberger.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of Maven Capital Pty Ltd (AFSL No. 418504). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.